Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study-Reference-Cited by-同舟云学术

Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study

Published:2022-06 Issue:6 Volume:39 Page:453-465
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Masurkar Prajakta P.^ORCID,Chatterjee Satabdi,Sherer Jeffrey T.,Chen Hua,Johnson Michael L.,Aparasu Rajender R.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

https://link.springer.com/content/pdf/10.1007/s40266-022-00944-z.pdf

Reference56 articles.

1. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327–406.

2. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomised clinical trials. BMJ. 2005;331(7512):321–7.

3. Koller D, Hua T, Bynum JP. Treatment patterns with antidementia drugs in the United States: medicare cohort study. J Am Geriatr Soc. 2016;64(8):1540–8.

4. Suh DC, Arcona S, Thomas SK, et al. Risk of antipsychotic drug use in patients with Alzheimer’s disease treated with rivastigmine. Drugs Aging. 2004;21(6):395–403.

5. Scharre DW, Vekeman F, Lefebvre P, Mody-Patel N, Kahler KH, Duh MS. Use of antipsychotic drugs in patients with Alzheimer’s disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study. Drugs Aging. 2010;27(11):903–13.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenylstyrylpyrimidine derivatives as potential multipotent therapeutics for Alzheimer's disease;RSC Medicinal Chemistry;2024

2. Analysis of electric field strengths and focality for healthy and neurologically impaired subjects upon multiple tDCS stimulation protocols;Research on Biomedical Engineering;2023-11-20

3. Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study;Clinical Therapeutics;2023-09

4. Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System;CNS Drugs;2023-06-21

5. Risk of SAEs with cholinesterase inhibitor use in elderly;Reactions Weekly;2022-06